The DOI matches its Crossref record.
Harnessing the Power of the Genome in the Search for New Antibiotics
Abstract
Over the past 40 years, the search for new antibiotics has been largely restricted to well-known compound classes active against a standard set of drug targets. Although many effective compounds have been discovered, insufficient chemical variability has been generated to prevent a serious escalation in clinical resistance. Recent advances in genomics have provided an opportunity to expand the range of potential drug targets and have facilitated a fundamental shift from direct antimicrobial screening programs toward rational target-based strategies. The application of genome-based technologies such as expression profiling and proteomics will lead to further changes in the drug discovery paradigm by combining the strengths and advantages of both screening strategies in a single program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655
Gerdes, S. Y., Scholle, M. D., Campbell, J. W., Balázsi, G., Ravasz, E., Daugherty, M. D., Somera, A. L., Kyrpides, N. C., Anderson, I., Gelfand, M. S., et al. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5673-5684.2003 · Cited by 725
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Nicolaou, K. C., Pfefferkorn, J. A., Roecker, A. J., Cao, G.-Q., Barluenga, S., & Mitchell, H. J. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002033k · Cited by 678
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 514
Lambert, P. A. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.7.x · Cited by 450
Ye, L., & Haupt, K. (2004) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2450-8 · Cited by 318
Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon
Mascher, T., Margulis, N. G., Wang, T., Ye, R. W., & Helmann, J. D. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03786.x · Cited by 310
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
YONEYAMA, H., & KATSUMATA, R. (2006) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 286
From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways
Gerdes, S. Y., Scholle, M. D., D'Souza, M., Bernal, A., Baev, M. V., Farrell, M., Kurnasov, O. V., Daugherty, M. D., Mseeh, F., Polanuyer, B. M., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.16.4555-4572.2002 · Cited by 282
Phylogenetic Framework and Molecular Signatures for the Main Clades of the Phylum Actinobacteria
Gao, B., & Gupta, R. S. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05011-11 · Cited by 281
Mascher, T., Zimmer, S. L., Smith, T.-A., & Helmann, J. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2888-2896.2004 · Cited by 281
Cell-division inhibitors: new insights for future antibiotics
Lock, R. L., & Harry, E. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2510 · Cited by 263
Virtual drug discovery and development for neglected diseases through public–private partnerships
Nwaka, S., & Ridley, R. G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1230 · Cited by 260
Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors
Henry, K. W., Nickels, J. T., & Edlind, T. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2693-2700.2000 · Cited by 216
De Backer, M. D., Ilyina, T., Ma, X.-J., Vandoninck, S., Luyten, W. H. M. L., & Vanden Bossche, H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1660-1670.2001 · Cited by 211
“In addition to providing a much more complete picture of which genes and pathways are involved, gene functions other than those currently known might be discovered (22).”
BackgroundAntibiotic research in the age of omics: from expression profiles to interspecies communication
Wecke, T., & Mascher, T. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr373 · Cited by 62
Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective
Cossar, P. J., Lewis, P. J., & McCluskey, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21519 · Cited by 55
Metadata
- Authors
- Rosamond, J., & Allsop, A.
- Venue
- Science
- Published
- 2000-03-17
- Volume
- 287
- Issue
- 5460
- Pages
- 1973-1976
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2028861967
- Cited by
- 186
- References
- 0
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.